STING1 and cancer: Of these known intracellular DNA sensors, STING was identified as a necessary upstream mediator in the type I IFN-dependent generation of endogenous antitumor immunity in immunogenic tumor types, identifying the STING pathway as a critical bridge to activate cancer immunity (25).